ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

Five Advocates Named To SWOG Committees; NCI, NASA Sign Nanotechnology Agreement.

April 21, 2000

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999